SCHEMBL1211902

SCHEMBL1211902

CCC(C)OC(=O)OC(C)CN[C@@H](Cc1ccc(OC(=O)OCCC(C)C)c(OC(=O)OCCC(C)C)c1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 5/20 0.38
DRD1 P21728 2/20 0.35
ATM Q13315 1/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRA2A P08913 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2C P18825 1/20 0.34
ADRA1A P35348 1/20 0.34
DRD3 P35462 1/20 0.34
ITGA4 P13612 1/20 0.33
ITGB7 P26010 1/20 0.33
LDHA P00338 1/20 0.33
PKM P14618 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MME P08473 2/20 0.32
ACE P12821 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1213161 0.96 ALOX15 (0.38) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1213374 0.94 ALOX15 (0.41) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1216255 0.94 ALOX15 (0.39) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1215233 0.93 ALOX15 (0.39) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1209895 0.93 ALOX15 (0.40) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1216612 0.93 ALOX15 (0.38) ALOX15DRD1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL1210954 0.93 ALOX15 (0.40) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1214369 0.93 ALOX15 (0.40) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1213070 0.93 DRD1 (0.41) ALOX15DRD1ATMALDH1A1KDM4E
SCHEMBL1215386 0.93 DRD1 (0.41) ALOX15DRD1ATMALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028544-A1 CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE XENOPORT, INC. (US) 2011-02-03 US disclosed
US-7829592-B2 Catechol protected levodopa diester prodrugs, compositions, and methods of use XENOPORT, INC. (US) 2010-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028544-A1 CATECHOL PROTECTED LEVODOPA DIESTER PRODRUGS, COMPOSITIONS, AND METHODS OF USE COMT, PARK7, DDT ALOX15 513/4885DRD1 88/4885ATM 3502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.